Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Автор: | Khandker, Tahia Anjum |
---|---|
Інші автори: | Kabir, Eva Rahman |
Формат: | Дисертація |
Мова: | English |
Опубліковано: |
Brac University
2024
|
Предмети: | |
Онлайн доступ: | http://hdl.handle.net/10361/22046 |
Схожі ресурси
-
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
за авторством: Islam, Nahidul
Опубліковано: (2023) -
Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
за авторством: Mahin, Md. Tamjidur Rahman
Опубліковано: (2024) -
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
за авторством: Afroza, Halima
Опубліковано: (2024) -
Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
за авторством: Bishakha, Adwiza Chakraborty
Опубліковано: (2024) -
SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
за авторством: Meem, Manila
Опубліковано: (2023)